Australia's largest stock trading and investment forum Australia's #1 stock forum

WHA

0.00%

48.7¢ wattle health australia limited

SAMR/CFDA Approval Processing, page-33

First 33 Last

Share
Profile

Follow
8horse

26,847 Posts.

1841

02/08/18

12:20

Post #: 34687664
Share

Originally posted by mcexplorer ↑

Got reply Without any indication of Approval stage:

Good morning,

The Weekly Times, which focuses on rural news primarily in Victoria, has followed up its initial news article last week on WHA with a news release.

Please read Peter Hemphill’s article which is attached.

Regards, Peter Nesveda

With content appended below:

Wattle Health in Chinese approval for sale of milk powder PETER HEMPHILL, The Weekly Times July 31, 2018 1:36pm UPDATE: SHARES in Wattle Health jumped nearly 50 per cent in three days last week after the company announced it had received Chinese approval for a milk powder product. The listed Australian dairy company has received approval for sale of 1kg retail bags of its grass-fed milk powder for supermarkets, pharmacies and “bricks and mortar” retail outlets. Wattle Health executive chairman Lazarus Karasavvidis said the approval was an important achievement for the company, as consumption of milk powders was greater than infant formulas. Mr Karasavvidis said Chinese approval for sale of the milk powder would expand its brand awareness. “This is a continuation of our China market strategy and ongoing commitment to making healthy, pure 100 per cent Australian-made produce available to our China consumers and supporting our extensive distribution partners,” he said. A day after Chinese approval for the milk powder was announced, Wattle Health said Corio Bay Dairy Group — a joint venture it had with Organic Dairy Farmers of Australia and Niche Dairy — had bought land in Geelong to build a dedicated plant for a spray dryer for organic milk powder production. The plant, to be located adjacent to ODFA’s existing dairy factory, is expected to be completed in September next year. Both stock market announcements pushed Wattle Health’s share price higher, rocketing from $1.045 a share last Tuesday to close $1.555 on Friday. By early trading today, the share price had fallen back to $1.405. Mr Karasavvidis said Wattle Health had first and last rights to powders produced at the Geelong plant. He said it would have annual capacity to process 60 million litres of organic milk into powders. He said ODFA had current organic milk production of about 35 million litres from its members but another 20 million litres under contract from farms converting to organic milk production. “There is a further 25 million litres under contract which they are securing (from farmers) joining their co-op.”

Expand

CFDA was very efficient, majority CFDA approvals received last year, were approved in about five months.
SAMR set-up did wasted one or two months times, in my view, WHA lodged last November, less two months lost time, formal approval shouldn't be too long.

WHA Price at posting: $1.45 Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Breaking news: New opportunities for investors & companies - HotCopper opens to capital raising!

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

There are more pages in this discussion • 21 more messages in this thread...

First 33 Last

Add WHA (ASX) to my watchlist

SAMR/CFDA Approval Processing, page-33

Top Stories

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Breaking news: New opportunities for investors & companies - HotCopper opens to capital raising!

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Featured News